Archimedes Pharma UK Ltd

250 South Oak Way, Green Park, Reading, RG2 6UG, UK
Telephone: +44 (0)118 931 5050
Fax: +44 (0)118 931 5056
WWW: http://www.archimedespharma.com

Patient Information Leaflet last updated on the eMC: 03/11/2010
PIL Pabrinex Intravenous High Potency Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to dosage and administration
  • Change due to user-testing of patient information
Updated on 12/05/2010 and displayed until 03/11/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 03/03/2009 and displayed until 12/05/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 15/09/2008 and displayed until 03/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 10/03/2008 and displayed until 15/09/2008
Reasons for adding or updating:
  • Change of licence holder
Updated on 21/06/2006 and displayed until 10/03/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   ascorbic acid
   pyridoxine
   nicotinamide
   thiamine
   glucose, anhydrous
   riboflavin